Australia markets closed

Neurotech International Limited (NTI.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.07800.0000 (0.00%)
At close: 03:59PM AEST

Neurotech International Limited

145 Stirling Highway
Suite 5 CPC
Nedlands, WA 6009
61 8 9389 3130

IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Alexandra AndrewsChief Operating Officer222.84kN/AN/A
Mr. Gerald QuigleyDirector of Public Relations & Director40.14kN/AN/A
Dr. Thomas Duthy M.B.A., Ph.D.Executive Director168kN/AN/A
Dr. Emanuela RussoChief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Peter James Lawrence Griffiths B.Sc.Chief Executive Officer of AAT Research LtdN/AN/A1964
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACGCompany SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.

Corporate governance

Neurotech International Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.